'Notice Of Removal By The Cooper Companies, Inc., Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc., Coopersurgical, Inc., Teva Pharmaceuticals Usa, Inc., Teva Women's Health, Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc. (filing Fee $ 400 Receipt Number 0313-14654888), Filed By The Cooper Companies, Inc., Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc., Coopersurgical, Inc., Teva Pharmaceuticals Usa, Inc., Teva Women's Health, Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'
'Disclosure Statement Form Pursuant To Frcp 7.1 By Teva Women's Health, Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'
'Disclosure Statement Form Pursuant To Frcp 7.1 By Coopersurgical, Inc..(rubenstein, Brian)'
'Disclosure Statement Form Pursuant To Frcp 7.1 By Teva Pharmaceuticals Usa, Inc..(rubenstein, Brian)'
'Disclosure Statement Form Pursuant To Frcp 7.1 By Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'
'Disclosure Statement Form Pursuant To Frcp 7.1 By The Cooper Companies, Inc..(rubenstein, Brian)'
'Answer To Complaint By Teva Pharmaceuticals Usa, Inc..(rubenstein, Brian)'
'Answer To Complaint By Teva Women's Health, Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'
'Answer To Complaint By Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'
Case number 2:20-cv-05249-HB was filed in the U.S. District Court for the Eastern District of Pennsylvania on Oct. 21.